Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 139
- Pharmaceutical
Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses
AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies released their latest financial figures.
- Adult-Use
Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest
LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total funding to date to over €100m.
- News
European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos
FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE), the market chaos caused by the UK Chancellor’s ‘mini budget’ has wiped £22,328,775 from the collective market value of LSE-listed cannabis stocks.
- Adult-Use
German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found
EARLIER this month news broke that recent analysis conducted by the Bundestag’s scientific service suggested the creation of a legal recreational cannabis market could contravene a number of European treaties which Germany had signed.
- Uncategorized
Deutsche SPD-Vertreter zuversichtlich, dass eine Lösung für internationale rechtliche Hürden gefunden wird
Anfang des Monats wurde bekannt, dass eine kürzlich vom Wissenschaftlichen Dienst des Bundestages durchgeführte Analyse darauf hindeutet, dass die Schaffung eines legalen Marktes für Freizeit-Cannabis gegen eine Reihe von europäischen Verträgen verstoßen könnte, die Deutschland unterzeichnet hat.
- CBD Market
Cellular Goods Reveals Plans For £18.6m RTO Deal With Cannaray Brands As Further CBD Consolidation Looms
SPECULATION that Cellular Goods was on the verge of being acquired has been swirling since early August when rumours of a looming deal saw its share price jump 40%, adding millions to its market capitalisation.
- Press releases
Akanda Plans First Shipment Of Medical Cannabis To Germany And Anticipates Leading Market Share Position
INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) expects to take a leading position in the fast-growing German medical cannabis market, as it prepares for first export shipment from its Portugal-based Holigen operation in the coming weeks.
- Uncategorized
Akanda plant die erste Lieferung von medizinischem Cannabis nach Deutschland und erwartet eine führende Marktposition
Das internationale Unternehmen für medizinische Cannabisplattformen Akanda Corp. (“Akanda” oder das “Unternehmen”) (NASDAQ: AKAN) erwartet, eine führende Position auf dem schnell wachsenden deutschen Markt für medizinisches Cannabis einzunehmen, da es sich auf die erste Exportlieferung von seinem in Portugal ansässigen Betrieb Holigen in den kommenden Wochen vorbereitet.
- Markets & Stocks
European Cannabis Stocks Review: Love Hemp Announces ‘Cessation’ Of LSE Listing Process, More From Cellular Goods & Stenocare
Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May this year, announced to investors this week that its application to be listed on the Standard Segment of the London Stock Exchange has now also ‘lapsed’.
- Adult-Use
Drug Coordinators From 27 EU Member States Meet In Prague To Discuss Cannabis Legalisation As Czechia Moves Closer To Recreational Market
EARLIER this month representatives from all 27 EU member states, alongside non-governmental experts, NGO’s and private sector representatives, came together in Prague for the annual National Drug Coordinators meeting.
- Adult-Use
European Cannabis Stocks Review: Akanda Signs With Cookies, IM Cannabis Sees Slight Recovery, & Futura Medical Prepares For FDA Approval
Markets across Europe opened lower this morning as ongoing and increasingly severe reports of a looming economic crisis pushed the FTSE 100, German DAX, French CAC 40 and the pan-European Stoxx 600 into the red.
- News
UK CBD Companies Are Being Forced To Diversify Their Businesses To Combat ‘Tremendously Worrying’ Financial Crisis
THE OFFICE for National Statistics (ONS) released more troubling news on the state of the UK’s economy this week, revealing that concerns around the cost of living led to ‘feeble’ growth in July, a month usually blessed with increased spending due to warm weather.










